TITLE

Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: Differences and similarities

AUTHOR(S)
Persico, Marcello; Masarone, Mario; La Mura, Vincenzo; Persico, Eliana; Moschella, Francesco; Svelto, Monica; Bruno, Savino; Torella, Roberto
PUB. DATE
January 2009
SOURCE
World Journal of Gastroenterology;1/28/2009, Vol. 15 Issue 4, p462
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
AIM: To investigate the prevalence of the clinical parameters of insulin resistance and diabetes in patients affected by chronic hepatitis C (CHC) or chronic hepatitis B (CHB). METHODS: We retrospectively evaluated 852 consecutive patients (726 CHC and 126 CHB) who had undergone liver biopsy. We recorded age, sex, ALT, type 2 diabetes and/or metabolic syndrome (MS), body mass index (BMI), and apparent disease duration (ADD). RESULTS: Age, ADD, BMI, prevalence of MS and diabetes in patients with mild/moderate liver fibrosis were significantly higher in CHC. However, the degree of steatosis and liver fibrosis evaluated in liver biopsies did not differ between CHC and CHB patients. At multivariate analysis, age, sex, BMI, ALT and diabetes were independent risk factors for liver fibrosis in CHC, whereas only age was related to liver fibrosis in CHB. We also evaluated the association between significant steatosis (> 30%) and age, sex, BMI, diabetes, MS and liver fibrosis. Diabetes, BMI and liver fibrosis were associated with steatosis > 30% in CHC, whereas only age and BMI were related to steatosis in CHB. CONCLUSION: These data may indicate that hepatitis C virus infection is a risk factor for insulin resistance.
ACCESSION #
36633603

 

Related Articles

  • Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia. Cortes-Mancera, Fabian; Loureiro, Carmen Luisa; Hoyos, Sergio; Restrepo, Juan-Carlos; Correa, Gonzalo; Jaramillo, Sergio; Norder, Helene; Pujol, Flor Helene; Navas, Maria-Cristina // Hepatitis Research & Treatment;2011, p1 

    Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the principal risk factor associated to end-stage liver diseases in the world. A study was carried out on end-stage liver disease cases admitted to an important hepatology unit in Medellin, the second largest city in Colombia....

  • Suppression of HBV by HCV. Wisecarver, J. L.; Thompson, Jon S. // American Journal of Gastroenterology;Nov1999, Vol. 94 Issue 11, p3109 

    Discusses research being done on the reduction of positive staining among patients infected with both hepatitis B and C viruses. Reference to a study by M. Guido and colleagues published in a 1999 issue of "Modern Pathology"; Process of diagnosing hepatitis B viral antigens in liver biopsies;...

  • Serum Aminotransferase Levels and Platelet Counts as Predictors of Degree of Fibrosis in Chronic Hepatitis C Virus Infection. Pohl, Annette; Behling, Cynthia; Oliver, Deanna; Kilani, Marwa; Monson, Petrea; Hassanein, Tarek // American Journal of Gastroenterology;Nov2001, Vol. 96 Issue 11, p3142 

    OBJECTIVE: In patients with chronic hepatitis C virus (HCV) infection, liver fibrosis stage is a prognostic factor for therapy outcome. So far, a liver biopsy is necessary to determine disease stage accurately. We sought to develop a simple. noninvasive method of accurately predicting the degree...

  • Hepatitis C and Metabolic Disorders: Genetics, Mechanism, and Therapies (Clinical and Experimental). Alvares-da-Silva, Mario Reis; Wedemeyer, Heiner; Cortez-Pinto, Helena; Souza de Oliveira, Claudia Pinto Marques // International Journal of Hepatology;2012, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including Hepatitis C virus influence on extrahepatic disease such as insulin resistance, chronic kidney diseases and diabetes mellitus.

  • Modulation of Tumor Necrosis Factor Receptors 1 and 2 in Chronic Hepatitis B and C: The Differences and Implications in Pathogenesis. Dar-In Tai; Sun-Lung Tsai, Philip K.; Tse-Ching Chen, Philip K.; Sing Kai Lo; Ya-Hui Chang, Philip K.; Yun-Fan Liaw // Journal of Biomedical Science;2001, Vol. 8 Issue 4, p321 

    Tumor necrosis factor (TNF) plays a role in the pathogenesis of chronic hepatitis B (CHB) and chronic hepatitis C (CHC). The difference in the cytokine responses between hepatitis B virus (HBV) and hepatitis C virus (HCV) infections may have implications in the pathogenesis of these diseases. We...

  • Early Detection of Chronic Liver Disease. Sornmayura, Kay // Clinician Reviews;Aug2010, Vol. 20 Issue 8, p24 

    The article discusses early detection of chronic liver disease such as hepatitis B and hepatitis C. It describes three case reports diagnosis of cirrhosis, hepatits B infection and cirrhosis secondary to hepatitis C. A discussion on the epidemiology of chronic hepatitis is offered. Other topics...

  • Prognostic effects of causative virus in hepatocellular carcinoma according to the Japan integrated staging (JIS) score. Kubo, Shoji; Tanaka, Hiromu; Shuto, Taichi; Takemura, Shigekazu; Yamamoto, Takatsugu; Uenishi, Takahiro; Tanaka, Shogo; Hai, Seikan; Yamamoto, Satoshi; Ichikawa, Tsuyoshi; Kodai, Shintaro; Hirohashi, Kazuhiro // Journal of Gastroenterology;Oct2005, Vol. 40 Issue 10, p972 

    Background. The Japan integrated staging (JIS) score is recognized to be useful in managing hepatocellular carcinoma (HCC). We evaluated the effects of the causative virus in patients stratified by this system. Methods. We compared clinicopathologic features, cumulative and tumor-free survival...

  • Cardiac extension of Hepatocellular carcinoma with pulmonary tumor- microembolism. Nepal, Manoj; Bhattarai, Alok; Adenawala, Humaira; Usman, Harris // Internet Journal of Gastroenterology;2008, Vol. 7 Issue 2, p7 

    Hepatocellular carcinoma is a primary liver cancer that arises as a result of chronic liver diseases either due to hepatitis B and C viruses or alcoholic and other liver diseases. It usually grows without extension into adjacent hepato-vascular structures. However, there are few case reports of...

  • Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis. Arase, Yasuji; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Akuta, Norio; Kobayashi, Masahiro; Kawamura, Yusuke; Yatsuji, Hiromi; Sezaki, Hitomi; Hosaka, Tetsuya; Hirakawa, Miharu; Saito, Satoshi; Ikeda, Kenji; Kumada, Hiromitsu; Saab, Sammy // World Journal of Gastroenterology;10/14/2008, Vol. 14 Issue 38, p5880 

    AIM: To investigate the cumulative development incidence and predictive factors for idiopathic pulmonary fibrosis in hepatitis C virus (HCV) positive patients. METHODS: We studied 6150 HCV infected patients who were between 40-70 years old (HCV-group). Another 2050 patients with hepatitis B...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics